Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman.

Int J Infect Dis

Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman; Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark.

Published: March 2020

Objective: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman.

Methods: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment.

Results: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved.

Conclusions: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2020.03.010DOI Listing

Publication Analysis

Top Keywords

estimate cost
8
cost screening
8
cost-effectiveness igra/qft-plus
4
igra/qft-plus screening
4
screening migrants
4
migrants oman
4
oman objective
4
objective estimate
4
screening program
4
program identifying
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!